BioSpace News Archive

Drug Development

Esperion’s Cholesterol Drug Positive in PhIII Trial

Esperion announced that its bempedoic acid for lowering LDL-C cholesterol had positive results in a Phase III clinical trial.

March 7, 2018
·
3 min read
·
Mark Terry
Biotech Bay

CDC Report Indicates Opioid Crisis in America is Worsening

The CDC report shows opioid-related emergency room visits spiked 30 percent over a period of one year.

March 7, 2018
·
2 min read
·
Alex Keown
Business

Moderna’s Vaccines Boss Leaves Company

Giuseppe Ciaramella, formerly chief scientific officer of Moderna Therapeutics’ Valera unit, has left for an unidentified stealth-mode biotech startup.

March 7, 2018
·
3 min read
·
Mark Terry
FDA

FDA Greenlights New Treatment for Multi-Drug Resistant HIV-1

The U.S. Food and Drug Administration has approved Trogarzo (ibalizumab), the first HIV-1 inhibitor for patients with multi-drug resistant HIV-1.

March 7, 2018
·
2 min read
·
Alex Keown
Drug Development

Seattle Genetics Commences Dosing in Early-Stage Multiple Myeloma Trial

Seattle Genetics dosed its first patient with an early-stage treatment for patients with relapsed or refractory multiple myeloma (MM).

March 7, 2018
·
2 min read
·
Alex Keown
Business

Roivant Licenses Diabetes Drug From Ligand Pharma

Ligand Pharmaceuticals is licensing LGD-6972, a glucagon receptor antagonist (GRA), to Roivant Sciences for $20 million.

March 7, 2018
·
3 min read
·
Mark Terry
Deals

Immuno-Oncology Sector Deals Dominate 2017 Life Sciences Deal of the Year Awards

Bristol-Myers Squibb acquisition of IFM Therapeutics, and Amgen-CytomX licensing deal recognized among more than 4,000 transactions in annual Cortellis Deal of the Year Awards from Clarivate Analytics

March 7, 2018
·
4 min read
Business

Trans-Hit Bio and Q&T Research enter into an Exclusive Strategic Business Partnership

Trans-Hit Bio (THB) is pleased to announce a strategic partnership with Q&T Research to facilitate access by the biopharma community to large quantities of blood collected by plasmapheresis from healthy donors and ambulatory patients that can be used to prepare the large volumes of PBMC.

March 7, 2018
·
1 min read
Business

Eloxx Pharmaceuticals Appoints Robert Ward Chairman and Chief Executive Officer

Eloxx Pharmaceuticals, Inc. (“Eloxx”) (OTCQB: SVOND), a clinical-stage biopharmaceutical company developing novel small molecule medicines...

March 7, 2018
·
5 min read
Business

CTI BioPharma Reports Fourth Quarter and Full Year 2017 Financial Results

CTI BioPharma Inc. reported financial results for the fourth quarter and full year ended December 31, 2017.

March 7, 2018
·
5 min read